Adherence to long-term therapies: evidence for action. 1. Patient compliance. 2. Long-term care. 3. Drug therapy – utilization. 4. Chronic disease – therapy.
Evidence for action. Geneva: WHO; 2003. Failure to take prescribed medicine for chronic diseases ... adherence to therapies averages 50% and the fig-.
(2003). Adherence to Long-term Therapies. Evidence for Action. World Health Organization. Retrieved from http://apps.who.int/medicinedocs/en/d/Js4883e/7.2.
Adherence
Adherence to long-term therapies: evidence for action. 1. Patient compliance. 2. Long-term care. 3. Drug therapy – utilization. 4. Chronic disease – therapy
recommendations” WHO ADHERENCE TO LONG-TERM THERAPIES: Evidence for action 2003. •Adherence rates with the statin therapy in elderly patients with and
GWCManifestoAdherenceChicago fullpage
17 août 2017 World Health Organization 2003. Adherence to long-term therapies - Evidence for action. 2. GINA (Global Initiative for Asthma) 2016.
fiche comment evaluer observance
▻Coût du traitement. D'après Sabaté E Adherence to long-term therapies: evidence for action. World Health Organization
jni observancebk dubee
(1) Adherence to long-term therapies – Evidence for action World Health Organization
observance Mollet
Cochrane Database Syst Rev. 2014(11):Cd000011. 14. WHO. Adherence to Long-term Therapies: Evidence for Action: World Health Organization;. 2003 [Available
inline supplementary material ?download=true
20 juil. 2022 Adherence to Long-Term Therapies Evidence for Action